drugset / Trial / NCT00792168
Physiologic Monitoring of Antidepressant Response
RandomizedParallel-groupDouble-blindTreatment
Summary
Primary: to identify physiologic indicators of venlafaxine treatment response using quantitative EEG (QEEG) cordance, and to determine if cordance changes are specifically associated with response to venlafaxine; Secondary: to determine if cordance changes early in the course (i.e., prior to improvement in clinical symptoms) of venlafaxine (or another antidepressant if venlafaxine is not clinically indicated for a particular patient) are predictive of later clinical response.
Timeline
- Start
- 1996-11
- Primary completion
- 1996-11
- Completion
- 1998-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Venlafaxine | Small molecule | 150 mg | — |